Empirical Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.23M Sell
22,032
-402
-2% -$83.5K 0.08% 155
2026
Q1
$4.74M Buy
22,434
+928
+4% +$200K 0.08% 156
2025
Q4
$4.42M Sell
21,506
-690
-3% -$130K 0.08% 154
2025
Q3
$3.48M Buy
22,196
+4,391
+25% +$678K 0.07% 172
2025
Q2
$2.99M Buy
17,805
+69
+0.4% +$10.2K 0.07% 181
2025
Q1
$2.44M Buy
17,736
+1,754
+11% +$224K 0.06% 188
2024
Q4
$1.89M Buy
15,982
+1,505
+10% +$176K 0.05% 205
2024
Q3
$1.6M Buy
14,477
+1,570
+12% +$164K 0.04% 213
2024
Q2
$1.27M Sell
12,907
-171
-1% -$17.4K 0.04% 234
2024
Q1
$1.46M Buy
13,078
+1,107
+9% +$119K 0.04% 219
2023
Q4
$1.21M Buy
+11,971
New +$1.19M 0.04% 222

Other funds holding CAH

Empirical Wealth Management's CAH Position: Q2 2026 in Review

Empirical Wealth Management reduced its Cardinal Health (CAH) stake by 1.8% in Q2 2026, selling an estimated $83.5K and leaving 22,032 shares worth $5.23M. The position accounts for 0.08% of the portfolio, ranked #155.

Empirical Wealth Management first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 551 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Empirical Wealth Management held 22,032 shares of Cardinal Health worth $5.23M as of Q2 2026.
  • Empirical Wealth Management sold 402 Cardinal Health shares in Q2 2026, an estimated $83.5K.
  • Cardinal Health made up 0.08% of Empirical Wealth Management's portfolio in Q2 2026, its #155 holding.
  • Empirical Wealth Management first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 551 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.